Circulation, Vol 55, 388-394, Copyright © 1977 by American Heart Association
E-GV Giardina, RM Stein and JT Bigger
The metabolism of sulfamethazine (SMZ), which is acetylated by a binodally
distributed enzyme, and procainamide (PA) was compared in 21 normal
volunteers, each given a single oral dosted metabolites, N-
acetyl-procainamide (NAPA) and Ac-SMZ, were measured. Subjects with less
than 64% Ac-SMZ in the 0-8 hour collection were termed "slow" and those
with more than 64% were termed "fast" SMZ acetylators. Slow SMZ acetylators
had 9.8 to 43.8% (24.1 +/- 10.13) NAPA recovered, and fast SMZ acetylators,
22.0 to 42.6% (33.7 +/- 7.29) NAPA, P less than 0.01. In addition, the
calculated half-life of PA metabolism for slow SMZ acetylators was 9.0 to
33.8 hours (18.4 +/- 8.82) and for fast SMZ acetylators was 8.1 to 14.4
hours (10.9 +/- 2.19), P less than 0.01. For four subjects, SMZ acetylation
phenotype did not correlate with the half-life of SMZ or PA metabolism; and
in two, SMZ acetylation phenotype and half-life of metabolism did not
correlate with the same PA indices. Even though slow SMZ acetylators have
less NAPA recovered than fast SMZ acetylators, it is not yet clear that
procainamide is metabolized by a bimodally distributed enzyme as is
sulfamethazine.
ARTICLES
The relationship between the metabolism of procainamide and sulfamethazine
This article has been cited by other articles:
![]() |
R. J. Straka and P. S. Marshall The Clinical Significance of the Pharmacogenetics of Cardiovascular Medications Journal of Pharmacy Practice, January 1, 1992; 5(6): 337 - 361. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |